Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus SODIUM CHLORIDE 0 9 IN STERILE PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus SODIUM CHLORIDE 0 9 IN STERILE PLASTIC CONTAINER.
MAGNESIUM SULFATE vs SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Sodium chloride 0.9% is an isotonic solution that provides sodium and chloride ions, essential for maintenance of osmotic pressure and fluid balance. It acts as a volume expander and vehicle for drug administration.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion; 0.9% sodium chloride is administered at a rate and volume determined by the patient's fluid and electrolyte needs, typically 500-1000 mL per hour for resuscitation or 100-200 mL per hour for maintenance.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateTerminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
The terminal elimination half-life of sodium and chloride ions is approximately 8-12 hours in individuals with normal renal function, reflecting the time required to excrete a load and reestablish homeostasis. In renal impairment, half-life is prolonged proportionally to the decrease in glomerular filtration rate.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Primarily renal excretion; >90% of administered sodium and chloride ions are eliminated unchanged in urine via glomerular filtration and tubular reabsorption. Less than 10% is lost through sweat, feces, and insensible losses.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."